374 related articles for article (PubMed ID: 30848854)
1. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.
Ooi CJ; Hilmi I; Banerjee R; Chuah SW; Ng SC; Wei SC; Makharia GK; Pisespongsa P; Chen MH; Ran ZH; Ye BD; Park DI; Ling KL; Ong D; Ahuja V; Goh KL; Sollano J; Lim WC; Leung WK; Ali RAR; Wu DC; Ong E; Mustaffa N; Limsrivilai J; Hisamatsu T; Yang SK; Ouyang Q; Geary R; De Silva JH; Rerknimitr R; Simadibrata M; Abdullah M; Leong RWL;
J Gastroenterol Hepatol; 2019 Aug; 34(8):1296-1315. PubMed ID: 30848854
[TBL] [Abstract][Full Text] [Related]
2. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.
Ooi CJ; Hilmi I; Banerjee R; Chuah SW; Ng SC; Wei SC; Makharia GK; Pisespongsa P; Chen MH; Ran ZH; Ye BD; Park DI; Ling KL; Ong D; Ahuja V; Goh KL; Sollano J; Lim WC; Leung WK; Ali RAR; Wu DC; Ong E; Mustaffa N; Limsrivilai J; Hisamatsu T; Yang SK; Ouyang Q; Geary R; De Silva JH; Rerknimitr R; Simadibrata M; Abdullah M; Leong RW;
Intest Res; 2019 Jul; 17(3):285-310. PubMed ID: 31146509
[TBL] [Abstract][Full Text] [Related]
3. Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.
Ooi CJ; Makharia GK; Hilmi I; Gibson PR; Fock KM; Ahuja V; Ling KL; Lim WC; Thia KT; Wei SC; Leung WK; Koh PK; Gearry RB; Goh KL; Ouyang Q; Sollano J; Manatsathit S; de Silva HJ; Rerknimitr R; Pisespongsa P; Abu Hassan MR; Sung J; Hibi T; Boey CC; Moran N; Leong RW;
J Gastroenterol Hepatol; 2016 Jan; 31(1):56-68. PubMed ID: 25819311
[TBL] [Abstract][Full Text] [Related]
4. Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1).
Ooi CJ; Makharia GK; Hilmi I; Gibson PR; Fock KM; Ahuja V; Ling KL; Lim WC; Thia KT; Wei SC; Leung WK; Koh PK; Gearry RB; Goh KL; Ouyang Q; Sollano J; Manatsathit S; de Silva HJ; Rerknimitr R; Pisespongsa P; Abu Hassan MR; Sung J; Hibi T; Boey CC; Moran N; Leong RW;
J Gastroenterol Hepatol; 2016 Jan; 31(1):45-55. PubMed ID: 25819140
[TBL] [Abstract][Full Text] [Related]
5. European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.
Doherty G; Katsanos KH; Burisch J; Allez M; Papamichael K; Stallmach A; Mao R; Berset IP; Gisbert JP; Sebastian S; Kierkus J; Lopetuso L; Szymanska E; Louis E
J Crohns Colitis; 2018 Jan; 12(1):17-31. PubMed ID: 28981623
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate for inflammatory bowel disease: time for reconsideration.
Nielsen OH; Ainsworth MA; Steenholdt C
Expert Rev Gastroenterol Hepatol; 2019 May; 13(5):407-409. PubMed ID: 30895827
[No Abstract] [Full Text] [Related]
7. Adverse events in IBD therapy: the 2018 update.
Quezada SM; McLean LP; Cross RK
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1183-1191. PubMed ID: 30791788
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.
Torres J; Boyapati RK; Kennedy NA; Louis E; Colombel JF; Satsangi J
Gastroenterology; 2015 Dec; 149(7):1716-30. PubMed ID: 26381892
[TBL] [Abstract][Full Text] [Related]
9. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Hanauer SB; Sandborn WJ; Lichtenstein GR
Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449
[TBL] [Abstract][Full Text] [Related]
10. Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.
Ran Z; Wu K; Matsuoka K; Jeen YT; Wei SC; Ahuja V; Chen M; Hu PJ; Andoh A; Kim HJ; Yang SK; Watanabe M; Ng SC; Hibi T; Hilmi IN; Suzuki Y; Han DS; Leung WK; Sollano J; Ooi CJ; Qian J
J Gastroenterol Hepatol; 2021 Mar; 36(3):637-645. PubMed ID: 32672839
[TBL] [Abstract][Full Text] [Related]
11. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.
Borman ZA; Côté-Daigneault J; Colombel JF
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1101-1108. PubMed ID: 30277409
[TBL] [Abstract][Full Text] [Related]
12. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases.
Han M; Jung YS; Cheon JH; Park S
J Gastroenterol Hepatol; 2019 Jul; 34(7):1166-1174. PubMed ID: 30672608
[TBL] [Abstract][Full Text] [Related]
13. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.
Bousvaros A
Expert Rev Clin Immunol; 2010 Jul; 6(4):659-66. PubMed ID: 20594138
[TBL] [Abstract][Full Text] [Related]
14. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.
Sturm A; Maaser C; Mendall M; Karagiannis D; Karatzas P; Ipenburg N; Sebastian S; Rizzello F; Limdi J; Katsanos K; Schmidt C; Jeuring S; Colombo F; Gionchetti P
J Crohns Colitis; 2017 Mar; 11(3):263-273. PubMed ID: 27797918
[TBL] [Abstract][Full Text] [Related]
15. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
16. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
17. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.
Renna S; Cottone M; Orlando A
World J Gastroenterol; 2014 Aug; 20(29):9675-90. PubMed ID: 25110407
[TBL] [Abstract][Full Text] [Related]
18. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Considerations in Inflammatory Bowel Disease.
McKenna NP; Lightner AL
Surg Clin North Am; 2019 Dec; 99(6):1083-1094. PubMed ID: 31676049
[TBL] [Abstract][Full Text] [Related]
20. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
